Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-centre, Open Label Extension Study to Evaluate the Long-term Safety, Tolerability and Efficacy of E2007 as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

NCT00360412 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT00360412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00360412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-centre, Open Label Extension Study to Evaluate the Long-term Safety, Tolerability and Efficacy of E2007 as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations
Lead sponsor
Eisai Inc.
Phase
Phase 3
Overall status
Terminated
Start date
October 31, 2006
Completion date
April 30, 2008
Enrollment
997 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease